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CONFLICT OF INTEREST IN THE PHARMACEUTICAL SECTOR:
A GUIDE FOR PUBLIC MANAGEMENT
Marc A. Rodwin1
Abstract
This article outlines the key kinds of conflicts of interest that exist in the
pharmaceutical sectors and shows how they affect 12 areas related to the
development, marketing, and distribution of pharmaceuticals. It explains
how these conflicts of interest can compromise good practice and
policy. Most importantly, it sets forth a step-by-step guide for managing
such conflicts of interest in the public and private sectors.
TABLE OF CONTENTS
I.
II.

What are Conflicts of Interest?
Twelve areas of Conflicts of Interest related to
pharmaceuticals
III.
Strategies to address Conflicts of Interest
IV.
Six Steps Public managers should take to cope with
Conflicts of Interest
Conclusion

1

2
6
10
13
25

B.A. Brown University; M.A., Oxford University; J.D. University of Virginia
Law School; Ph.D., Brandeis University Heller School. Professor of health law and
policy at Suffolk University Law School and the 2017-18 Chair in Integrated
Cancer Research at IMERA Institute, Aix Marseille University, Marseille France.
Suffolk University Law School, 120 Tremont Street, Boston, MA, 02108;
marcrodwin@gmail.com; Tel: 617-573-8354. Marc Rodwin is the author of
Conflicts of Interest and the Future of Medicine: The United States, France and
Japan (2011) and Medicine, Money and Morals: Physicians’ Conflicts of Interest
(1993). Acknowledgements: Work on the article supported in part by the Institute
for Health Law, University of Neuchâtel, IMERA Institute, University AixMarseille, France, and Suffolk University Law School. Thanks to Eric Lindstrom
for help with citations.

2

Marc A. Rodwin. Conflict of Interest in the Pharmaceutical Sector
I.

WHAT ARE CONFLICTS OF INTEREST?

The pharmaceutical sector plays a vital role in the promotion of
individual health care and public health. However, the conflicts of interest
in the pharmaceutical sector compromises the integrity of medical practice,
appropriate prescribing, patient safety, and public health.2 It can also lead to
governments, insurers, and patients paying more for medications. Increased
costs mean increased social burden that imposes an unnecessary limit on
global access to essential medicines.
Conflicts of interest can compromise the integrity of key parts of the
pharmaceutical sector. Policies that preclude, manage, or mitigate conflicts
of interest promote the integrity of governmental decisions and decisions by
medical professionals, who play strategic roles related to the use of
medications. Public policies that promote transparency, like policies that
target overt corruption are therefore aligned with conflicts of interest
policies but distinct from them.3 This article describes conflicts of interest
in the pharmaceutical sector and ways public policy can address them.
The idea underlying conflicts of interest is simple: it is implicit in the
principle that no individual can judge his or her own case because that
would mix two incompatible roles, playing both the participant and the
judge. A judge is supposed to be unbiased when deciding the outcome of a
case. However, a judge cannot be neutral when he or she must decide a case
that pits the judge—or member of the judge’s family—against another
party. Similarly, a judge who has strong financial ties or a close friendship
with one party in a court case is also likely to be biased in that party’s favor.
Other governmental officials also exercise authority that affects the
public. These public servants also have obligations to make decisions fairly,
to fulfill their public mission impartially despite their personal interests. Yet
administrators and public servants sometimes have personal interests that
can bias their decisions.

2

Marc A. Rodwin, Conflicts of Interest, Institutional Corruption, and Pharma:
An Agenda for Reform, 40 J. OF L. MED. & ETHICS 511, 511-22 (2012).
3
See generally Guitelle Baghdadi-Sabeti et al., Measuring Transparency in the
Public Pharmaceutical Sector, WORLD HEALTH ORGANIZATION [WHO] (2009),
http://apps.who.int/medicinedocs/documents/s16732e/s16732e.pdf; See generally
Jillian C. Kohler et al., Corruption in the Pharmaceutical Sector: Diagnosing the
Challenges, TRANSPARENCY INTERNATIONAL UK (2016),
https://www.transparency.cz/wp-content/uploads/Corruption-in-the-PharmaSector.pdf.
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Physicians, pharmacists, and other professionals working in both the
public and the private sectors also have obligations to serve the interests of
designated parties or to perform certain public functions. Yet these
professionals sometimes have a personal stake in matters that can cause
them to favor their own interests over the interests of their patients, clients,
or other parties they are supposed to serve.
A. Definitions
This article uses as its starting point the traditional legal definition
used by the Organization for Economic and Cooperative Development
(OECD), which focuses on conflicts of interest of public sector actors.4 The
OECD says that, “‘a conflict of interest’ involves a conflict between the
public duty and private interests of a public official, in which the public
official has private-capacity interests, which could improperly influence the
performance of their official duties and responsibilities.”5
Bear in mind that conflicts of interest do not constitute a breach of
duty. Although law or ethics may require individuals to not enter into
conflict-of-interest situations, this is only a measure to prevent acts
considered wrong in themselves. Conflicts of interest can influence action,
but they are not acts and do not constitute a breach of trust. Furthermore,
conflicts of interest are distinct from conflicting interests. Multiple interests
often pull people in different directions. But unless such conflicting
interests compromise an individual or party’s obligations, no conflict of
interest exists.
Conflicts of interest constitute a problem for two reasons: (1) they
compromise an actor’s loyalty to her mission or the parties they are
supposed to serve, and (2) they compromise the actor’s independent

4

The Organization for Economic Co-operation and Development [OECD]
uses the traditional legal definition. Some writers have attempted to redefine
conflicts of interest with confusing results. See Marc A. Rodwin, Attempts to
Redefine Conflicts of Interest, ACCOUNTABILITY IN RESEARCH 67, 67-78 (2018).
5

OECD, Managing Conflict of Interest in the Public Service: OECD
Guidelines and Country Experiences (2004),
http://www.oecd.org/gov/ethics/48994419.pdf [hereinafter Country Experiences];
See also OECD, Managing Conflicts of Interest in the Public Sector: A Toolkit
(2005), https://www.oecd.org/gov/ethics/49107986.pdf [hereinafter A toolkit] See
also, MARC A. RODWIN, MEDICINE, MONEY AND MORALS: PHYSICIANS’
CONFLICTS OF INTEREST, 629-34 (1993); MARC A. RODWIN, CONFLICTS OF
INTEREST AND THE FUTURE OF MEDICINE: THE UNITED STATES, FRANCE, AND
JAPAN 15-16 (2011) [hereinafter The Future of Medicine].
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judgment.6 Consequently, conflicts of interest increase the risk that
individuals will not perform their duties as they should, or even cause them
to breach their obligations. The least serious form of breach could be
professional neglect: a compromised public employee might not perform at
his or her customary high level of competence, diligence, or effectiveness.
In its most egregious form, public servants and publicly employed
professionals may knowingly exploit their position. Extreme disloyalty
obviously presents more dramatic danger but is easier to identify. Situations
that compromise independence, loyalty, or judgment more subtly or even
unintentionally, occur more frequently but are harder to recognize.
B. Some Distinctions
Individual Conflicts of Interest
Two main kinds of conflicts of interest exist: Financial and Divided Loyalty
Conflicts
Financial conflicts of interest arise when an individual has financial
interests that can affect decisions he makes when performing his duties.
These personal interests might present a strong incentive to ignore public
duty and bias the official towards his or her own wallet, or the wallet of
friends and family. Divided loyalty conflicts of interest arise when an
individual’s loyalty is split between two parties with differing interests. An
individual can engage in multiple activities that are acceptable when
considered individually, yet often conflict when one individual performs
them simultaneously.
Potential and Apparent Conflicts
The OECD uses the term “potential conflict of interest” for
situations in which an official would have a conflict of interest if there were
certain changes in their official work activities or in the individual’s
activities outside of work such that the individual would then have a
conflict between his work duties and personal interests.7
The OECD reserves the term apparent conflict of interest for
situations where it appears to many observers that a public official’s private
interests could improperly influence their performance of professional
duties, but where in fact there is no conflict because arrangements have

6

MARC A. RODWIN, MEDICINE, MONEY, AND MORALS: PHYSICIANS’
CONFLICTS OF INTEREST 8-11 (1993); Rodwin, supra note 4, at 15-17.
7

Country Experiences, supra note 3, at 58.
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been made for the official to stand aside from all decision-making related to
the activities in which the official would have a conflict.8
For example, a public servant with an ownership interest in a private
firm has a potential conflict of interest because the public servant has a
private interest in the success of the firm that might conflict with the
official’s exercise of her duties. However, if the public servant works in the
transportation ministry and is an investor in a pharmaceutical firm or
pharmacy, the public servant’s work is unlikely to affect the private firm or
vice versa. If the public servant is reassigned to work in a bureau that
approves the marketing of medicines or that regulates pharmacies, then the
public servant’s financial interest will likely create an actual conflict of
interest. The test is whether the performance of public duties by the public
official can influence decisions in favor of the business in which the official
has financial ties.
Similarly, an individual who works in a pharmaceutical affairs
bureau, and whose sister manages a pharmaceutical firm, has an apparent
conflict of interest because it appears that the official’s duties will conflict
with his interest in helping his sister’s firm. It remains an apparent conflict
rather than an actual conflict of interest if arrangements have been made so
that the official will not participate in any pharmaceutical bureau decisions
that affect the firm in which the official’s sister is a manager.
Conflicts of Interest of Professionals in the Private Sector
Professionals working in the private sector can also have conflicts
of interest when they serve on government commissions or advisory boards
or offer expert advice to public officials. Under these circumstances, these
professionals perform public functions and therefore are expected to act as
if they were performing their work as public employees. Yet these
professionals might have financial interests affected by the outcome of their
public decision. Consequently, they might be in a situation where they can
perform their public sector functions in ways that promote their private
interests.
Furthermore, there can also be conflicts of interest for professionals
that work in private practice even when they do not perform any work for
the public sector. For example, physicians and pharmacists have
professional obligations to act in the best interests of their patients and to
comply with professional norms. Since these professionals earn their living
by performing their professional work, their personal financial interests can
create an incentive for them to write prescriptions, offer advice, or generally
8

Id.
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make decisions that promote their personal financial interests over the
interests of their patients.
Institutional Conflicts of Interest
An institutional conflict of interest exists when an organization
performs two or more roles that can conflict.9 This typically occurs when
the institution has financial interests that can cut against an institutional
mission or activity. Some writers also hold that when an institution’s senior
official has financial interests that can affect institutional policies, that
situation also creates an institutional conflict of interest.10 However, the
financial interests of senior officials in an organization can also be analyzed
as reflecting their individual conflicts of interest.
In the United States, many private not-for-profit universities and
hospitals have joint ventures with for-profit firms to conduct research and
commercialize products derived from the research.11 The university or
hospital will share profits or royalties from pharmaceuticals or other
products derived from the research. Meanwhile, these universities have a
mission of promoting inquiry and public access to knowledge and
obligations to oversee the integrity of university researchers and to monitor
the financial conflicts of interest of researchers. In this situation, the
university has a financial interest in the outcome of the research that can
conflict with its mission as an educational and research institution.12 For
example, if an institution conducts research to evaluate a pharmaceutical
product while earning income from the product’s sale, those two activities
create an institutional conflict of interest.

9

Id. at 66.

10

See generally Association of American Universities, Report on Individual
and Institutional Financial Conflict of Interest (2001),
http://ccnmtl.columbia.edu/projects/rcr/rcr_conflicts/misc/Ref/AAU_CoI.pdf;
Bernard Lo & Marilyn J. Field, Conflict of Interest in Medical Research,
Education, and Practice, INSTITUTE OF MEDICINE OF THE NATIONAL ACADEMICS
[IOM] (2009), http://www.kumc.edu/Documents/coi/TOC.pdf.
11

SHELDON KRIMSKY, SCIENCE IN THE PRIVATE INTEREST: HAS THE LURE OF
PROFITS CORRUPTED BIOMEDICAL RESEARCH? 27-56 (2004); See Mark Barnes &
Patrik S. Florencio, Financial Conflicts of Interest in Human Subjects Research:
The Problem of Institutional Conflicts, 30 J. L. MED. & ETHICS 390, 390 (2002).
12

Ezekiel J. Emanuel & Daniel Steiner, Institutional Conflict of Interest, 332
NEW ENG. J. MED. 262, 262 (1995).
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II.

TWELVE AREAS OF CONFLICTS OF INTEREST
RELATED TO PHARMACEUTICALS

Conflicts of interest compromise good pharmaceutical policy in 12
related areas. These areas occur in multiple points in the medication life
cycles. These include, at the beginning of the medication life cycle, research
on safety and effectiveness required prior to marketing the drugs. At the end
of the medication life cycle they include monitoring drug safety after drugs
are on the market. In between there are 10 additional points where decisions
about medications present opportunities for conflicts of interest.
Exhibit A, below, displays these twelve areas roughly in the chronological
order.
Exhibit A
Twelve Areas of Conflicts of Interest in the Medication Life Cycle
1)
Safety/
Effectiveness
Research

2)
Medical
Publication

3)
Registration
/Marketing
authorizatio
n)

4)
Reimbursement
& Pricing

5)
Mfg. &
Distribution

6)
Procurement

7)
Standard
Treatment
Guidelines

8)
Formulary
Selection

9)
Continuing
Education

10)
Prescribing

11)
Dispensing

12)
PostMarketing
Drug Safety

Research to Test Medicines for Safety and Effectiveness
Governmental authorities require that pharmaceutical products be tested
for safety and effectiveness before they authorize their sale. Typically,
governments require that manufacturers submit evidence of safety and
effectiveness derived from clinical trials. The results of clinical research to
test medicines can therefore influence whether a medicine can be sold, for
what purposes it can be marketed, the claims that manufacturers can make
when marketing the medicine, and the warnings of health risks that
manufacturers must provide. The information from clinical research also
often affects the choices made by authorities that regulate medicine prices,
the decisions of purchasers and prescribers, the medicine formularies
developed by hospitals and health systems, and choices that patients make.

8
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Many pharmaceutical researchers have conflicts of interest,
including the individuals who design clinical trials or carry out the research
or interpret and report the data. These researchers are supposed to provide
objective evaluation of a pharmaceutical product, but pharmaceutical firms
that wish to commercialize a medicine are often the ones who pay the
researchers to conduct the research. Other times, pharmaceutical firms
employ these researchers as consultants or offer them grants and gifts.
These researchers might conduct their work in a way that promotes results
favoring the interest of the pharmaceutical firms with which they have
financial ties.
Medical Publication
Medical journals publish articles reporting on clinical trials that evaluate
pharmaceutical products. These articles affect the decisions of physicians,
pharmacists, and policymakers. The authors of medical journal articles can
have financial ties with pharmaceutical firms and these ties can bias their
publications. Medical journal peer reviewers can also have financial ties
with pharmaceutical firms, and these ties can bias their evaluation. For
example, both authors of journal articles as well as peer reviewers might
depend on pharmaceutical firms for employment, consulting income or
grants and gifts. In addition, medical journals often depend on revenue from
pharmaceutical firms’ advertising for and purchasing of article reprints.
Registration of Pharmaceuticals (authorization to market, approved uses,
labeling)
National authorities typically regulate the marketing of medicines by
setting rules for registration and sale of pharmaceutical products. These
rules are intended to protect the public. If the public officials working in
these agencies have financial interests in the pharmaceutical firms they
regulate, then these public officials have conflicts of interest that can bias
their decisions regarding the sale of pharmaceuticals.
Frequently, public authorities ask experts in the private sector to
advise them regarding the registration of pharmaceutical products. When
these experts earn income from pharmaceutical firms, then in turn offer
advice to public authorities on sale of the pharmaceutical firm’s products,
the experts have a conflict of interest.

9
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Regulation of Reimbursement and Pricing
Many nations regulate the price of pharmaceutical products. If
decision makers have financial ties with pharmaceutical firms then conflicts
of interest are created that can affect governmental pricing decisions.
Pharmaceutical Manufacturing, Distribution, and Oversight of Pharmacies
Governments oversee the pharmaceutical manufacturing process by
setting standards for quality controls and good manufacturing practices. The
public employees who oversee these processes have conflicts of interest
when they receive gifts or have other financial ties with these firms.
National authorities typically inspect pharmaceutical manufacturing
facilities. Governments oversee the process of distributing pharmaceuticals
through controls on imports and rules for storage, transportation, and
delivery. The public employees who oversee this process have conflicts of
interest when they receive gifts or have other financial ties with the firms
involved in the distribution process. National authorities also often inspect
pharmacies and other pharmaceutical facilities. Inspectors with financial
ties to the firms they regulate have conflicts of interest that compromise
their work.
Procurement
Public authorities, private insurers, hospitals, and other parties often
procure medicines. When choosing among various products and deciding
what price to pay, these parties are supposed to act in the interest of the
entities they serve. However, these individuals and organizations sometimes
have financial ties with pharmaceutical firms or intermediary organizations;
these relationships create conflicts of interest that can bias their
procurement choices.
Standard Treatment or Practice Guidelines
Standard treatment guidelines draw on existing medical knowledge
to establish recommendations for good medical practice. These guidelines
shape physician prescribing and clinical choices. In some countries (e.g.,
France) governmental authorities set practice guidelines. Other nations
adapt WHO’s standard treatment guidelines (e.g., Ghana). In many other
countries, medical specialty societies and insurers develop medical practice
guidelines, including guidelines for medicine therapy. The professionals
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who serve on committees that draft guidelines sometimes have financial ties
to companies that can bias their decisions in drafting the guidelines.
Formulary Selection Committees (by government, private insurers, and
hospitals)
Hospitals and insurers typically develop formularies that restrict
which pharmaceutical products physicians can prescribe or affect the copayments that patients pay. Individuals who serve on formulary committees
and have financial ties with pharmaceutical firms have conflicts of interest
that can bias the formulary choices.
Continuing Professional Education Related to Pharmaceuticals
Continuing medical education (CME) shapes the knowledge and
perceptions of professionals on clinical issues, including the appropriate use
of pharmaceutical products. Organizations that develop CME programs and
the CME speakers themselves can have conflicts of interest due to their
reliance on grants from pharmaceutical firms to finance the program or
from pharmaceutical firms paying for the CME speaker’s fees or from
speakers and CME providers with other financial ties to drug firms. These
conflicts can bias the information that physicians receive and influence their
prescribing.
In most countries, pharmaceutical firms play a major role in
financing CME, often providing discretionary grants on topics they choose.
They can thereby promote programs on topics related to their products.
CME funders sometimes can also affect the choice of speakers at CME
events and oversee the written materials used by speakers. This kind of
pharmaceutical firm influence affects the content of materials presented. In
some countries, drug firms also reimburse travel expenses of attending
physicians; financial support that creates opportunities to influence
physicians.
Pharmaceutical Prescribing
In most countries, many pharmaceuticals are restricted to patients
with a prescription from a designated professional. Physicians and other
practitioners are supposed to prescribe medicines for the benefit of their
patients. Yet, drug firms seek to influence prescribers. Drug firms often
offer grants and gifts to prescribers or employ them as consultants to
influence their prescribing choices.
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DePaul Journal of Health Care Law 2019; Vol. 21 No. 1

Pharmaceutical Dispensing
In some countries, physicians and other prescribers can also
dispense medicines, own pharmacies, or have ties with pharmacies (or
facilities that dispense medicines). When prescribers earn income from
dispensing medicines or from having financial ties to organizations that
dispense medicines, this creates a conflict of interest. Under those
circumstances, the dispensing professional can increase his income by
changing his prescribing choices. For example, the professional might
prescribe more medicines than necessary, or select one medicine over
another to boost his own income.
Post-Marketing Drug Safety
Most countries rely on manufacturers to conduct post-marketing
evaluation of their products and to report information on adverse reactions
to national registration authorities. However, the incentives of
manufacturers are often at odds with the interests of public safety. That
conflict may cause them to invest insufficient resources to monitoring drug
safety, to delay reports on adverse reactions and risks and to bias their
analysis of risks.13

III.

STRATEGIES TO ADDRESS CONFLICTS OF INTEREST

There are three main strategies used to address or cope with
conflicts of interest (See Exhibit B: Conflicts of Interest: Intervention
Points).14 For the purpose of illustration, we will assume the individual with
a conflict of interest is a government employee or public servant. However,
this also applies to other individuals who have conflicts of interest and are
employed in the private sector.

13

Marc A. Rodwin, Five Un-Easy Pieces of Pharmaceutical Policy Reform, 41
J. L. MED. & ETHICS 581, 584-85 (2013).
14

See The Future of Medicine, supra note 3, at 207.
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Exhibit B
Conflicts of Interest: Intervention Points
PREVENTION
-Before
public servant acts

REGULATION
-During
public servant acts

SANCTIONS/RESTITUTION
-After
public servant acts

Prohibit

Supervise

Penalize

public servants
from entering into
situations with
conflicts of interest

conduct of public
servants and limit
their discretion

public servants for
violations of trust

Disclose
conflicts of interest

Compensate
those harmed if public servants
abuse their trust

The first strategy is to prevent the conflict of interest from occurring
or to eliminate the conflict when it arises. This can be done by organizing
the work of government authorities in ways that preclude key actors from
entering into situations in which they would have a conflict of interest.
Alternatively, when individuals have a conflict of interest, the individual or
their employer can eliminate the conflict.
The second strategy is to regulate the conduct of key actors who
have conflicts of interest. This requires identifying key actors with conflicts
of interest, then supervising their conduct. Overseeing the conduct of a
conflicted actor can sometimes mitigate conflicts of interest. Reducing the
discretion of key actors can decrease the risk that they will act in ways that
are biased or breach their trust. Furthermore, if public authorities monitor
the conduct of conflicted actors and suspect they have acted inappropriately,
the authorities can overrule their decisions.
The third strategy is to allow individuals to have conflicts of interest
but to impose sanctions or provide restitution when public servants or
publicly employed professionals have breached their duties. This approach
assumes that the risk of being sanctioned will deter individuals from
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breaching their obligations and that in any event, sanctions and restitution
will provide adequate remedies when public employees breach their trust.
The advantage of policies that preclude conflicts of interest from
occurring is that this approach avoids the risks that conflicts of interest
create. However, rules that preclude conflicts of interest usually restrict
many activities, some of which are beneficial. For example, a rule that
prohibits public employees from engaging in any outside remunerative
activity will preclude many conflicts of interest. However, it might also
preclude governmental employees from supplementing their income from
activities that do not create conflicts of interest. A public employee in the
pharmaceutical affairs department will not have conflicts of interest when
she spends her weekends writing magazine articles on films and popular
culture.
A more nuanced approach is to eliminate conflicts of interest only
after they arise. This approach restricts activities only when they are
necessary to resolve the conflict. For example, an employee who reviews
applications to market new medicines has a potential conflict of interest if
they have a relative that works for Wonderpharma. When Wonderpharma
submits an application to market a new medicine and the application is one
the employee would normally review, the employee’s potential conflict of
interest becomes an actual conflict of interest. The disadvantage of waiting
until a conflict actually arises is that such strategy relies on the ability to
identify the conflict and take appropriate action. However, such conflict of
interest might not be identified if administrators cannot monitor the
financial interests of employees and the manner in which their work
activities might affect their financial interests.
The advantage of employing policies that oversee conflicted actors
is that these policies would not preclude potentially beneficial activities that
might give rise to conflicts of interest. However, overseeing the activities of
conflicted actors usually requires the use of significant resources, and it is
difficult to properly execute.
The advantage of policies that rely on sanctions and restitution is
that they avoid preclusion of wide categories of activities as a preventive
measure. It also avoids expending resources to monitor the conduct of
conflicted actors. However, the disadvantage is that it is often difficult to
identify breaches of trust, and sanctions often fail to provide an adequate
remedy. Moreover, while sanctions can provide a remedy for breach of
trust, they cannot provide remedies when the effect of a conflict of interest
is biased governmental decisions.
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IV.

SIX STEPS PUBLIC MANAGERS SHOULD TAKE TO
COPE WITH CONFLICTS OF INTEREST

Step 1: Develop a Framework to Govern the Conduct of Public Employees
and Private Sector Experts Who Advise the Government.
The first step is to develop policies and a legal framework that will
govern the conduct of public employees and elected or appointed public
officials. Such rules should apply to all public employees, not only those
whose work concerns pharmaceuticals. It is possible, however, to have
distinct rules for employees working in ministries concerned with
pharmaceuticals.
Typically, after there is agreement on the basic policy, implementing
the policy will require enacting legislation and/or the promulgation of
administrative rules. These rules should set standards for the conduct of
public employees and for private sector individuals who perform public
functions, such as advising public officials or serving on government
commissions. These rules can be part of civil service laws or separate laws
that regulate the conduct of public employees and government officials.
These rules should set standards for the conduct of employees and
therefore include provisions that are broader than merely setting standards
for conflicts of interest. These rules should include legal requirements and
codes of conduct or ethics that supplement legal requirements. These rules
should include anti-corruption measures (such as prohibitions on accepting
or paying kickbacks or bribes or other breaches of public trust) and should
specify prohibited activities because they are incompatible with certain
public employment and public service. For example, the rules should
restrict public employees from accepting gifts from parties affected by their
work; they should also preclude employees from operating a business
enterprise that contracts with the government. These rules might also
prohibit public employees from exercising leadership positions in a political
party or in an organization that seeks to change government policy on
matters related to the employee’s work.
Rules for public employment should restrict employees from
participating in activities that create conflicts of interest. The rules should
prohibit public officials from engaging in certain conduct and from having
certain financial ties that create conflicts of interest. Other parts of this
article provide examples of the kinds of activities that can be restricted (See
Box 1: Sources of Conflicts of Interest for Public Employees). It is unlikely
that public employment rules will preclude all conflicts of interest.
Therefore, policies are needed to address conflicts of interest as they arise.
Furthermore, rules are needed to govern the conduct of individuals

15
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employed in the private sector who serve on governmental advisory boards
or who perform other public functions.
A public servant’s post-employment work can create conflicts of
interest in three ways. First, public employees can provide favors to a
regulated firm or to the industry more generally and in return receive a
highly paid position in that industry after the employee leaves government
service. An explicit offer of employment after leaving public office in
return for a favor from a government official violates many public
corruption laws. However, public officials do not have to make an explicit
agreement; they might offer favorable treatment to pharmaceutical firms in
expectation that the favor will be returned after they leave government
service. Second, public officials often obtain confidential information that is
valuable to the regulated industry and use that information to obtain
lucrative post-public sector employment that relies on their knowledge of
such confidential information. Third, public employees often develop
personal relations with other officials, and a wide range of contacts with
decision-makers. These employees can sometimes use these contacts and
relationships after leaving government service to help regulated parties
influence policy decisions. To address these problems many nations
regulate certain activities of individuals after they leave public employment.
Step 2: Develop Measures to Implement and Enforce Conflict of Interest
Policy.
Public authorities need a mechanism to implement conflict-ofinterest policies because they do not implement themselves. These
mechanisms should include programs to educate and train public employees
regarding legal standards, compliance, and how to resolve conflict-ofinterest problems.
Policies that lack enforcement mechanisms have little value. There
need to be public officials who are responsible for enforcing the conflict-ofinterest rules. If responsibility for overseeing conflicts of interest is
delegated to government officials with numerous responsibilities, these
officials will often focus their attention on other matters and neglect
conflicts of interest. Therefore, it is preferable that the public officials
charged with this task make implementing and enforcing conflict of interest
policies their sole or primary responsibility.
There must be consequences when government officials (or private
sector actors who perform some other public function) violate conflict-ofinterest policies. First, there must be means to challenge and rescind
governmental decisions when the responsible actors failed to comply with
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conflict-of-interest rules. If a governmental commission included members
who violated conflict of interest rules, then the decision of the commission
should be deemed to lack legal authority.
Disciplinary consequences are also required for public officials who
fail to declare their financial interests or who report false information.
These consequences can include negative employment evaluations,
restrictions on promotions, removal from public employment or office,
monetary fines, or criminal penalties. There also must be a means to
discipline individuals employed in the private sector who violate conflict of
interest rules when serving on governmental commissions or advisory
boards.
Step 3: Develop Measures to Promote Ethical Conduct and Voluntary
Compliance.
There should be codes of conduct and other measures to promote
compliance with policies that require employees to report their personal
financial interests and to avoid activities that are incompatible with their
government position. Voluntary compliance is not a substitute for a system
of legal and administrative rules to enforce these standards, but it is a useful
supplement. An ethical culture is an important component in making
conflict-of-interest policy effective because there are limits on what the law
can achieve without most employees making good faith efforts to comply.
For this reason, governmental authorities should create an
organizational culture that promotes these values.15 As part of this effort,
employers could develop codes of conduct or ethical codes for employees
and train employees on how to comply. There also need to be laws that
protect whistleblowers, individuals who report unlawful, dishonest, or
corrupt governmental activity. Without such protection, many employees
will be not report misconduct because they fear that powerful government
officials will retaliate and jeopardize their careers.
Step 4: Require Key Actors to Declare their Financial Interests.
In order to manage conflicts of interest, it is necessary to identify
them and that requires information about the work that public employees
perform, their personal financial interests, and their activities outside of
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WHO, Good Governance for Medicines: A Model Framework (2014),
http://apps.who.int/medicinedocs/documents/s21548en/s21548en.pdf.
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their employment that can create conflicts of interest.16 Therefore, public
policy should require that certain employees report to authorities on a
regular basis, information on their financial interests, and activities that
could conflict with their work duties. Bear in mind, disclosing financial
interests does not eliminate or cure any conflict. Declarations of interest are
not an end in themselves, but they are necessary to identify and manage
conflicts of interest.17
All public employees who exercise administrative, managerial, or
policymaking responsibilities, or who perform professional roles, should
report certain interests using a standard form. The forms should enumerate
the specific categories of interests that employees must declare. These
interests should include both the interests of the public employee and also
those of their immediate family members.18 Individuals should file
declarations of interest on an annual basis and, in addition, whenever they
assume major new job responsibilities, or their personal financial interests
undergo a significant change. (See Box 2: Declarations of Interests.)
Governments should also require declarations of interest by private
sector employees who serve on government commissions or advisory
boards or who advise the government in other contexts. These individuals
should complete declaration forms developed by public authorities that
report the same information from public employees.
Employees should disclose financial interests: income, gifts over a
nominal value, investments, and ownership interests. Income should include
money, in-kind benefits, and other items of economic value. Employees
should also declare activities outside of government employment that could
conflict with their work duties. These activities could include certain
uncompensated working relationships such as serving on boards of
corporations or not-for-profit organizations, and significant work for
political parties.19
Some conflict-of-interest policies only require employees to declare
interests that directly relate to their employment duties or the activities of
the ministry in which they work. The rationale is that interests not directly
16

See, e.g., U.S. Department of Health and Human Services, Financial
Disclosure by Clinical Investigators (February 2013),
https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm341008.pdf.
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A Toolkit, supra note 3, at 27.
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18 U.S.C. § 208 (a) (2012).
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5 C.F.R. § 2635.502 (a)(2)(b)(1)(iv)-(v) (1992); 5 C.F.R. § 2635.502
(a)(2)(b)(1)(iv)-(v) (2017).
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related to an individual’s work duties are irrelevant and cannot create a
conflict of interest. Such policies effectually reduce the information
required to be disclosed and protect employee privacy.
However, merely asking employees to decide whether a personal
interest is relevant to their work entails risk. Employees often fail to see the
relevance of a financial interest that is apparent to officials charged with
overseeing conflicts of interest. Moreover, declarations of interests
sometimes reveal a potential conflict of interest that can later become an
actual conflict. Unless the potential conflict of interest is identified it cannot
be managed. Most important, when individuals do not report personal
interests because they consider them irrelevant, that precludes an objective
review of whether a conflict of interest exists. Therefore, it is preferable to
require declarations of all interests. It is the responsibility of governmental
authorities, not the employee who files the declaration, to determine
whether an employee has a conflict of interest, and how it should be
managed.
Step 5: Identify Individual and Institutional Conflicts of Interest.
Individual Conflicts of Interest
Designated officials need to analyze declarations of interest filed by
employees in order to identify potential and actual conflicts of interest. The
officials who review these declarations should be trained to identify
conflicts of interest. These officials can include an attorney working in the
government’s office of legal affairs, a compliance officer, or an official
designated to oversee the ethics of governmental personnel. The reviewers
should distinguish between financial interests that are related to the
employee’s work and those that are not. Some governments prohibit all
outside employment or remunerative activity while others allow employees
to engage in certain limited outside employment (See Box 3: Analyzing
Conflicts of Interest Check List).20
Identifying conflicts of interest requires examining the individual’s
work responsibilities in relation to their personal interests and outside
activities. The first step is to identify the employee’s duties and the
activities of the ministry in which the employee works. Employees can have
20

5 U.S.C. § 502 (2011); Jack Maskell, Outside Employment, “Moonlighting,”
by Federal Executive Branch Employees, CONGRESSIONAL RESEARCH SERVICE
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conflicts of interest when they are involved in government decisions such as
setting general policies, granting authorization to market pharmaceutical
products, approving the conduct of pharmaceutical firms through inspection
of manufacturing, or participating in the awarding of contracts and licenses
or permits. Employees can also have conflicts of interest when they have
access to confidential information.
It is important to examine the scope of an employee’s duties. Certain
high and middle-level employees can affect government policy on a wide
range of matters. They might also be able to exercise power or influence
over other employees. When these employees have conflicting outside
interests, it can affect a broad scope of government activity. In contrast,
other employees often have a narrowly defined scope of responsibility and
authority and can affect governmental decisions only on limited matters.
They have fewer opportunities for conflicts of interest than when an
employee exercises broad authority.
After identifying the kinds of decisions that the employee can
influence, responsible officials should examine the employee’s declarations
of interest to learn whether the employee has personal financial interests or
engages in outside activities that might give rise to a conflict of interest.
(See, Box 1: Sources of Conflicts of Interest for Public Employees.)
Responsible officials should look at the individual’s: 1) Personal financial
interests; 2) Financial interests and activities of family: including their
spouse, betrothed, or individual with whom they cohabit; their parents;
siblings and children; 3) Gifts; 4) Employment outside of public service; 5)
Appointments outside of governmental work; 6) Employment after leaving
government service.
Declarations of interest can reveal financial ties arising from
ownership and investment that can create conflicts of interest. Employees
who earn income from ownership, investment, royalties, or patents related
to pharmaceuticals cannot play a neutral role in making decisions related to
the enterprises that generate that income. The issue that reviewers then need
to ask is whether the employee participates in work that could affect those
private enterprises and whether the employee’s interest in the private
enterprise can affect their public employment activities.
Declarations of interest might reveal that the employee has a conflict
of interest arising from the interest of a family member of the employee.
The public employee’s loyalty to their family might bias the public
employee to favor the interests of a relative.
Declarations of interest can also reveal that employees have received
gifts or grants from businesses related to the employees’ work or from
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individuals employed in those businesses. Some governments prohibit
public employees from accepting any gifts. When public policy does not
prohibit all gifts, they typically require their disclosure so responsible
officials can respond appropriately.
Most nations prohibit public employees from accepting gifts of any
value from individuals or firms engaged in activities related to the
employees’ work.21 However, some nations allow certain kinds of gifts or
grants to support publicly employed physicians, researchers, or other
employees. For example France allows pharmaceutical firms to pay for
transportation and lodging for physicians to attend professional meetings
and CME so long as the physician and pharmaceutical firm disclose the
financing and they follow certain rules.22 Typically, the funds must be used
to finance the cost of participating in professional activities, such as
attending professional meetings or training, or to finance research. Some
nations allow public employees to accept business hospitality, such as a
meal, if the value falls below a certain threshold.
Some governments prohibit public employees from engaging in any
remunerated outside employment. When government employees are
permitted to engage in limited outside employment, certain work can create
conflicts of interest. For example, working part-time for a pharmaceutical
firm will typically create a conflict of interest for employees in government
ministries that oversee pharmaceutical policy. It could bias the employee to
favor the pharmaceutical firm when he or she makes governmental
decisions. In contrast, working part-time for an enterprise outside the
pharmaceutical sector would typically be unrelated to the employee’s work
and would not conflict.
In some situations, it will be necessary to examine the outside
employment closely to determine if there is a conflict of interest. When an
employee works part-time for a law firm or consulting organization, that
21

See Eric Raile, Managing Conflicts of Interest in The Americas: A
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work does not necessarily concern pharmaceutical matters related to the
employee’s government employment. However, if the law or consulting
work concerns pharmaceutical issues, then there might be a link. Reviewers
need to probe which firms and types of businesses the law or consulting
firms serves and the matters on which the employee worked.
Declarations of interest might also reveal certain unremunerated
activities that create conflicts of interest. For example, a government
employee who serves on the board of a firm or not-for-profit organization
can develop relationships with those private sector entities that could lead
the employee to favor that organization. This typically creates a conflict of
interest if the ministry in which the employee works regulates the private
sector organization with which the government employee is affiliated.
Responsible governmental authorities also need to review the postemployment activities of certain government employees to determine if they
comply with conflict of interest rules. These reviews are not, strictly
speaking, a review of declarations of interest in the same sense as public
employees. More often it will be a statement indicating the former
employee’s current employment, their work responsibilities, and a
statement that they have complied with rules on post-government
employment. For example, governments often restrict employees for a
designated number of years from representing any private sector actor in
matters before the agency in which the former employee worked.
Institutional Conflicts of Interest
These are the five steps needed to identify an institutional conflict of
interest: 1) Specify the organization’s mission and its activities; 2) List the
organization’s financial interests and its source of funds (including all
revenue, grants, royalties, and ownership interests; 3) List the
organization’s affiliations with other organizations; 4) Review the
institution’s mission, activities, financial interests, and affiliations to see if
there are potential conflicts among them; 5) Finally, ask whether combining
these activities could compromise performance of any one of them. Also
ask whether the institution’s financial interests could bias the performance
of its activities or pursuit of its mission.
Step 6: Resolve or Manage Conflicts of Interest
Assess the Significance of a Conflict of Interest
Conflicts of interest are widespread; their potential impact is
sometimes difficult to assess. Some are minor and can be ignored without
much risk of harm. But there is no simple way to determine to what degree
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a conflict of interest compromises an individual’s loyalty, judgment, and
fulfillment of their obligations. In each case, we must review the facts and
context to reach a conclusion. When a declaration of interests reveals a
potential or actual conflict of interest, then officials have the responsibility
to assess the significance of the conflict and decide what action to take.
Some financial conflicts of interest are more serious than others. We
can reasonably expect that the risk posed by compromising financial ties
increases as the amount of money involved increases. As a practical matter,
public policy often accepts the presence of certain small financial conflicts
of interest in order to focus on more significant conflicts. However, research
shows that even small gifts and financial ties often create feelings of
gratitude and generate reciprocity.23 Hence, there are also grounds to restrict
the existence of small ties.
We need to ask several questions. How strong or direct are the
conflicts? What is the probability of inappropriate behavior? What kinds of
risk are posed? How serious might the consequences be? What effect would
measures to eliminate or manage the conflict have on other goals?
Some employees might play such an important role in decisionmaking that it is prudent to manage even their potential conflicts of interest
in order to avoid likely problems if an actual conflict of interest arises.
However, not all potential and actual conflicts of interest are of the same
importance. In some cases, the responsible official might conclude that the
conflict of interest is so small that no action needs to be taken aside from
disclosing the conflict in the name of transparency.
When a significant conflict of interest arises, however, public
officials need to take action to either resolve or manage the conflict. It is
often tempting for responsible officials to assume that rules on conflicts of
interest should be waived because the government employee or private
sector expert is essential and there is no way to resolve or manage the
conflict of interest. In most cases, this is not true. There should be few if
any waivers of rules and when they occur, the basis for the decision should
be justified in writing and made public.
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Resolve Individual Conflicts of interest
Two main strategies can be employed to resolve a conflict of
interest: A) change the compromised employee’s relationship to the private
interest; B) change the compromised employee’s work activities.
A) Change The Compromised Employee’s Relationship to the Private
Interest
•

Divest the private ownership interest

The employee can sell their ownership or investment interest in the private
entity. Severing the financial ties eliminates the conflict of interest.
•

Terminate the relationship with the private entity.

The employee can resign from the board or cease other relationships with
the private entity in order to end the conflict.
•

Place the employee’s investment interests in a blind trust

The employee’s stock or other investment can be placed in a blind trust
managed by an independent party that has no contact with the public
official. This will prevent the government official from controlling their
investments while the official is in a position to make decisions that can
affect those investments. The trustee has authority to manage the investment
portfolio through sales and purchases but cannot consult with the public
official. This option is typically used for high-level public officials who
own stock in publicly traded firms.
B) Change The Compromised Employee’s Work Activities
•

Resign: The official can end his public employment and thereby end
the conflict.

•

Recusal: The public official can withdraw from participating in any
governmental decisions that can affect her private financial
interest.24

•

Reassign work duties: The employee’s duties can be changed so that
the official does not work on activities that can affect her private

24

Recusal are an effective tool when the conflict of interest will occur very
infrequently.
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interests. The employee can be reassigned to work in a different
division or her work duties can be modified in other ways.
•

Restrict access to information: The government can limit the
employee’s access to information that might be used to advance her
private interests. Typically, when government officials work on
general policy and regulatory matters it makes sense to preclude
their conflicts of interest. The reason is that it is difficult to separate
particular work activities and decisions that can affect the official’s
private interests from work activities that do not. It is therefore not
administratively feasible to cope with the conflict by restricting only
discrete employment activities. Resolving the conflict requires
severing the employee’s financial tie to the pharmaceutical firm or
changing the employee’s work responsibilities.

In contrast, when public employees do not work on general policy
matters but work on making discrete decisions that only concern particular
firms, it is often possible to distinguish potential from actual conflicts of
interest. This makes it feasible to change the employee’s work
responsibilities in order to preclude a potential conflict of interest from
becoming an actual conflict of interest.
Sometimes government policies restrict public employees who work
in a regulatory capacity from having any financial ties with a regulated
industry to preclude even potential conflicts of interest. Alternatively,
governments could minimize restrictions and permit financial ties that
create potential conflicts of interest if it is possible to separate the
employee’s activities that can affect the firms with which they have a
financial tie from activities that will not affect the firm.
Resolve Institutional Conflicts of interest
Institutional Conflicts of interest can be resolved in the following ways:
•

Change the intuition’s responsibilities to eliminate conflicting roles;

•

Terminate the institution’s financial ties that create a conflict of
interest.

Manage Conflicts of Interest
When it is not feasible to resolve conflicts of interest, they can be
managed to reduce the risk of bias or misconduct. There are two main ways
to do so.
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1) Oversee the Work of Conflicted Public Employees

One option is to oversee or supervise the conflicted employee to
reduce the risk that the employee will abuse the public’s trust. The
employee’s supervisor can check on her performance and modify her
decisions if the employee acts inappropriately. It is worth noting that this
kind of supervision is costly, burdensome, and difficult to do well. There is
a significant risk that the planned oversight will be done ineffectively.25
Furthermore, written plans for supervision can create the appearance that
the conflict of interest is being effectively managed when in fact it is not.
Supervision as a safeguard is used with varying degrees of success in two
contexts outside of public employment.
First, American universities oversee the conflicts of interest of
clinical researchers who have financial interests in the research.26 The
preferred practice is to bar individuals who have financial interests in a
particular medicine or method of therapy from conducting research to
evaluate the therapy. However, sometimes the university allows the
individual to participate in the research subject to certain restrictions. For
example, the conflicted researcher might be allowed to play a role in the
research but not be allowed to direct the project. Alternatively, the
university might set up a committee to monitor the research and data
produced.27 If the conflict of interest can affect the enrollment of human
research subjects the university might require the presence of a patient
representative to monitor the process of enrolling research subjects and
obtaining their consent. However, the effectiveness of these practices
remains unevaluated and there is significant reason to believe that they
often are not effective.28
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A second example of managing conflicts of interest arises in the
case of American insurers. Physicians paid fee-for-service often have a
conflict of interest because they have a financial incentive to prescribe the
services that they provide. In response to this common situation, American
insurers created or adopted practice guidelines. The health insurers then
appoint utilization reviewers to determine whether physicians have
prescribed services or medications that do not conform to practice
guidelines. The insurers typically have the authority to overrule the clinical
choices of these physicians or to refuse payment for services deemed
medically unnecessary according to medical practice guidelines.29
The system of utilization review by private health insurers described
above is rarely used outside the United States. Instead, many countries have
adopted WHO standard treatment guidelines for therapeutic use of
medications.30 Many nations use these standard treatment guidelines to
restrict the use of medications through pharmaceutical formularies in public
hospitals and national health insurance systems.
2) Minimize the Role of Conflicted Actors
If a conflicted individual participates in a group that makes a
decision, the conflicted individual’s influence decreases as the number of
people who participate in the decision increases. Consider, for example, a
conflicted expert who serves on a commission to recommend whether to
approve marketing of a medicine. The conflicted expert’s vote will have
greater weight if five rather than twelve individuals serve on the
commission. Reducing the number of conflicted experts that serve on a
commission decreases the risk that bias will determine the results.
Nevertheless, the conflicted expert can also influence the outcome by
convincing others who serve on the commission to adopt her point of view,
so conflicted individuals have more influence than their vote alone.
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Manage Institutional Conflicts of Interest
Institutional conflicts of interest are more difficult to manage than
individual conflicts of interest because organizational leaders often have
their own professional interests aligned with the institution’s short-run
interests. They are therefore likely to find it challenging to take actions that
restrict organizational activities that create the institutional conflicts of
interest. Institutional leaders can try to address this problem by appointing
managers without conflicts of interest to manage the institution’s conflicts
of interest. They may employ the following strategies:
•

Create firewalls that separate the functions of different parts of the
organization that have conflicting functions or financial interests;

•

Limit contact between individuals who work in different divisions of
the organizations that have conflicting interests and financial
interests.

CONCLUSION
This article outlined twelve areas in which conflicts of interest
compromise pharmaceutical policy and practice and six steps policymakers
should take to identify, eliminate, or manage such conflicts. Many conflicts
of interest can be eliminated or managed when they are identified.
However, effectively coping with conflicts of interest requires the existence
of a legal framework, institutions to oversee conflicts of interest, a clear
strategy, and resources to implement these public policies.
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Appendix:
Conflicts of Expert Advisors in the Private Sector
Frequently, governments seek the help of experts who are not public
employees to advise them on various issues, including: 1) whether to
approve the registration, marketing, and sale of a new pharmaceutical
product (and if so on what terms); 2) whether to add a pharmaceutical
product to a list of essential medicines or a formulary list that determines
which medicines will be available at public hospitals and clinics; or 3) the
level of reimbursement the government should pay for purchase of a
pharmaceutical product. The government will often appoint these
individuals to serve on governmental commissions or advisory boards.
When these individuals advise the government, they perform a public
function and are supposed to act on behalf of the public. However, because
they work in the private sector, they might have financial ties with
pharmaceutical firms that create a conflict of interest. These financial ties
can include employment or consulting with a pharmaceutical firm, receipt
of research grants, or gifts from a pharmaceutical firm or from a foundation
affiliated with a pharmaceutical firm.
To avoid conflicts of interest, rules should restrict who can serve on
advisory boards. The rules should exclude employees of a firm that
manufactures, sells or markets pharmaceutical products as well as
individuals who have financial ties with a firm whose products might be
affected by decisions of the advisory board.
When a government advisory board meets to determine whether a
firm should be allowed to market a new medicine, the board should not
include any former employee of that firm. Similarly, the board most likely
should not include any individual who has worked for a firm that markets a
medicine or that competes with the firm seeking to market the new
medicine. When developing a list of products to be included in a medicine
formulary or list of essential medicines, the government commission should
not include experts who have worked for a firm whose products might be
included on the list. When a commission makes recommendations on
reimbursement for the sale of a medicine, the best practice is for the
commission to exclude individuals who have worked for the firm that
manufactures that product, or who have worked on a competing medicine.
Government officials sometimes seek to waive rules that exclude
conflicted actors because the actors have special qualifications that are
difficult to find and because they believe the conflict of interest is small and
will not have any effect on the actor’s conduct. Certainly, having a large
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financial interest in a matter presents a greater risk than a small one.
Therefore, it often makes sense to establish a financial threshold below
which income from a pharmaceutical firm will not preclude an expert
serving on a commission. Likewise, rules might ignore financial ties from
work many years in the past on the grounds that they will not have any
effect on the individual’s conduct.
Nevertheless, studies on the effects of gifts and other financial
incentives reveal that they can create bias even when they are small.
Furthermore, individuals with an existing working relationship with a
pharmaceutical firm (even if the work only generated modest revenue and
occurred several years ago) might want to avoid taking action that could
damage that relationship and jeopardize future consulting income.
Therefore, it is preferable to bar individuals with conflicts unless there is no
alternative.
Sometimes administrators believe that they cannot find individuals
without conflicts of interest to advise them. This is rarely, if ever, true. For
example, the kind of expertise needed to serve on an advisory board that
evaluates whether to approve the marketing of a new medicine, does not
require expertise in the medicine or the disease it treats, although that might
be helpful. Typically, what is required is the ability to evaluate medical
studies and literature, and to critically evaluate claims of the medicine
sponsor. Many more individuals will have that expertise than specialized
knowledge in a particular medicine or illness. Furthermore, if unconflicted
experts do not reside in the locality, it is possible to engage the services of
an expert who lives outside the nation.
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BOX 1: CONFLICTS OF INTEREST OF PUBLIC EMPLOYEES
1) Personal Financial Interests, Investment and Ownership Interests
•

The employee’s investment and ownership interest or other
financial interests that conflict with work duties can be a source
of conflicts of interest. There is a risk that an official who invests
in or owns an entity that can be affected by her work will use her
work position to favor their investment interest.

2) Family Members’ Financial Interests And Activities
•

The employee’s family members’ financial interests and
affiliations can be a source of conflicts of interest.

3) Gifts and other Benefits from Private Interests
•

Public officials who receive gifts, grants, favors, or other benefits
from private entities might act to help those private entities.

4) Supplemental Private Employment
•

Sometimes the law allows public employees to engage in part-time
employment or other remunerative activity in the private sector.
Some of these private remunerative activities can interfere in the
official’s performance of her public duties.

5) Private Sector Appointment and Performing Unpaid Work for
Private Entities
•

Public officials might serve on a board or advise a private entity
without compensation on matters that concern their work activity.
There is a risk that the officials will use their access to government
information to favor one entity over another or that in performing
their public duties the public official will favor the entity with which
they have an affiliation.

6) Post-Governmental Employment
•

Employment after leaving government service can create a conflict
of interest in two ways. First, while working in the public sector, the
official might try to secure a job in the private sector by granting
special favors to a regulated firm. Second, after leaving public
service, the public official might use confidential information
obtained while publicly employed to benefit the private firm.
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BOX 2: DECLARATIONS OF INTERESTS
The declaration forms should ask employees to disclose for themselves and
their family the following interests. The employee answer should indicate
the purpose of the private entity and its activities. The form should specify
any activities that are related to the employee’s work, namely work on
pharmaceutical matters.
Ownership and Investment Interests
• Real estate (excluding family home)
• Ownership or shares in private companies (sole proprietorships,
partnerships, limited partnerships, stock ownership, other
investments interests)
• Patents
Income generated through work or contracts with firms in private sector
• Part-time employment
• Consulting
• Royalties
• Corporate distributions
• Serving on boards
• Honoraria
• Fees for speaking
• Contracts that have generated or can generate other income
Loans from entities other than banks, credit unions
• Loans from private firms
Gifts from firms or individuals employed by a business related to the
employee’s work
• Cash
• Goods or objects worth more than $20
• Meals worth more than $20
• Transportation provided by private entities or travel expenses
reimbursed greater than $20
• Other business hospitality and entertainment
Affiliations with Firms and Not-For-Profit Organizations
• Directorships
• Appointments
• Leadership positions
Family Members (Spouse or domestic partner, parents, siblings, children)
• Employment or business activity of immediate family members. For
purposes of disclosure, family members should include individuals
to whom they are betrothed or with whom they cohabit.
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BOX 3: A CHECK LIST TO ANALYZE CONFLICTS OF INTEREST
I)

Is there a conflict of interest?

1)
2)
3)
4)

Who is the actor and what is his/her designated role?
To whom does the actor owe a legal or ethical duty?
What is the nature of that duty or obligation?
Does the actor have a financial tie, a secondary activity or a
secondary role that creates a risk that the actor will not fulfill her
duty?
5) When the actor exercises professional discretion, can the actor
promote his/her own financial interest or the financial interest of a
third party?
II)
1)
2)
3)

III)

How significant is the conflict of interest?
Is the financial incentive for the actor so strong that it may cause
him to behave in ways that promote his/ her own self-interest or
that of a third party?
How much discretion does the actor have in making professional
decisions?
What are the potential risks/ harms that can result if the actor is
biased in exercising his/ her discretion or the actor violates his/
her duties?
What policy options exist to eliminate, mitigate, or help
manage the conflict of interest?

Consider at least these kinds of options:
1) Changes in the organization and financing of medical care;
2) Separation of professional roles or activities;
3) Restrictions on having certain financial ties or relationships;
4) Oversight of professional activity to reduce discretion or monitor
performance;
5) Disclosure of financial ties to allow patients and other parties to
protect themselves or to facilitate monitoring and management of
professionals with CI;
6) Remedies after a breach of duties (such as restitution to individuals
harmed an penalties for individuals who violate their duties).

